BUSINESS● LOWAug 4 · Aug 4, 2026, 12:48 PM
Lisata Therapeutics moves forward with legal action following Kuva merger termination
Yahoo Finance
Lisata Therapeutics is pursuing legal action after the termination of its merger with Kuva. This indicates a significant legal development in the business world, stemming from a failed corporate merger.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS31m agoNetflix options chain flooded with deep puts ahead of earningsSeeking Alpha TechBUSINESS31m agoData center stocks slide as Korea IPO plunges 30%, pressuring tech sentimentCNBC